1 янв 2007 г. - Food and Drug Administration Amendments Act of 2007

Описание:

Specifically authorized FDA to require manufacturers post-marketing clinical studies to monitor for risks infected during the pre-market approval process
Also required REMS programs where necessary. What is a REMS program?

Добавлено на ленту времени:

Дата: